$10.17
+0.78 (+8.31%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+131.6% upside
Low Target
$16.79
Average Target
$23.55
High Target
$35.63
Current Price
$10.17
Current
$10.17
$10.17
Target
$23.55
$23.55
$16.79
$23.55 avg
$35.63
Scenario Analysis
Bear Case
$16.79
65.1%
Low target
Base Case
$23.55
+131.6%
Avg target
Bull Case
$35.63
+250.3%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$12.54
-18.9% from high
52-Week Low
$2.24
+354.0% from low
Target vs 52W High
$23.55
+87.7% vs high
Next Earnings Report
Nov 12, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.21
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |